BioForce Nanosciences Holdings, Inc.

OTCPK:BFNH Stock Report

Market Cap: US$40.5m

BioForce Nanosciences Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Steve Gagnon

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownershipn/a
Management average tenure2.5yrs
Board average tenureno data

Recent management updates

No updates

Recent updates


CEO

Steve Gagnon (61 yo)

2.5yrs

Tenure

Mr. Steven Gagnon, also known as Steve, is Co-Chief Executive Officer at BioForce Nanosciences Holdings, Inc. since November 30, 2021. He was a Director of Bravo Multinational Incorporated since November 2...


Leadership Team

NamePositionTenureCompensationOwnership
Aleksandr Shapiro
President2.5yrsno datano data
Steven Gagnon
Co-Chief Executive Officer2.5yrsno datano data
John LaViolette
Co-Chief Executive Officer2.5yrsno datano data
Richard Kaiser
CFO, Corporate Secretary7.4yrsno data17.25%
$ 7.0m

2.5yrs

Average Tenure

61.5yo

Average Age

Experienced Management: BFNH's management team is considered experienced (2.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.